Inuk Zandvakili

Inuk Zandvakili is a Physician Scientist at the University of Cincinnati, affiliated with the Department of Internal Medicine and specializing in Gastroenterology and Hepatology. With clinical experience from Mayo Clinic and a dual MD/PhD background in Molecular and Developmental Biology, they focus on metabolic disorders, liver disease, and obesity treatment. Their research integrates clinical practice with genomic analysis, including collaborations with teams at University of Pennsylvania and Regeneron.

• Education: PhD in Molecular and Developmental Biology (University of Cincinnati), MD (University of Cincinnati), BS in Biochemistry (University of Western Ontario)
• Certifications: American Board of Internal Medicine, Gastroenterology Board Certification

Their work explores the intersection of GLP-1 agonists, genetic variants (MLXIPL, MTARC1), and liver disease prevention, with recent studies analyzing aspirin's protective effects, statin therapy, and bile acid interventions. Publications span journals like Gastroenterology, Hepatology Communications, and JAMA Network Open.

Clinical interests include digestive diseases and gastroenterology, with contributions to endoscopic safety guidelines and obesity management strategies. They maintain active collaborations with researchers at Regeneron, UK Biobank, and Regensburg University Medical Center.